Fountain Life Holdings, LLCSeries B-1 / B-2 Investment Opportunity
$75M 2026 ARR | 5 Centers | 14.4% Life-Saving Finds | March 2026
Company Overview
Fountain Life is the world's leading science-backed longevity platform, adding healthy decades to members' lives through advanced diagnostics, personalized health plans, and cutting-edge therapeutics — all powered by AI. The company operates at the intersection of an $8 trillion market opportunity (UBS, 2030) with first-mover advantage in premium AI-powered diagnostics.
Key Metrics at a Glance
$75M
2026 ARR
Budgeted annualized run rate
+160%
Revenue CAGR
3-year compound growth
85%+
Recurring Revenue
Membership dues as % of total
~19.5x
LTV:CAC
Best-in-class unit economics
14.4%
Life-Saving Finds
Critical early detection rate
81.6
NPS Score
World-class satisfaction
Financial Trajectory
| Year | Revenue | EBITDA | Centers |
|---|---|---|---|
| 2022 | $32.8M | ($17.8M) | 3 |
| 2023 | $60.4M | ($20.6M) | 4 |
| 2024 | $51.4M | ($13.9M) | 4 |
| 2025E | $57.0M | ($5.2M) | 4 |
| 2026E | $75.0M | $6.5M | 6 |
| 2027E | $122.0M | $24.5M | 8 |
| 2028E | $182.0M | $53.0M | 10 |
2030 Vision
$250M
Revenue Target
$65M
EBITDA Target
12 Centers · 8,000+ Members
The Compounding Moat
DATA MOAT
15B+ clinical data points — largest proprietary longevity dataset. Every member visit trains Zori AI.
CLINICAL MOAT
Full-body MRI, GRAIL, DEXA, CT, and AI analysis in a single visit. No competitor offers this breadth.
OPERATIONAL MOAT
Repeatable playbook with 39% center margins. Standardized 18-month ramp model.
Valuation & Comparable Analysis
| Company | Revenue | EV/Revenue | Growth | Margin |
|---|---|---|---|---|
| Fountain Life | $57M ARR | 5.3x | +160% | 39% |
| Function Health | $100M+ | 25x | +400% | Neg. |
| Hims & Hers | $1.2B | 5.2x | +69% | 15% |
| One Medical (acq.) | $1.0B | 4.5x | +62% | Neg. |
| Privia Health | $1.7B | 2.8x | +23% | 5% |
| Oak Street (acq.) | $2.0B | 5.0x | +55% | Neg. |
Premium positioning justified by growth rate, retention, and market opportunity.
Use of Funds — $22M Series B-1 / B-2
82% center expansion · 9% digital · 9% pre-development
2026 Center Performance
Naples, FL
Flagship — relocating to larger facility
$16.7M
43% margin
Orlando, FL
Lake Nona Medical City partnership
$19.9M
41% margin
Dallas, TX
Fastest ramping center in history
$17.1M
43% margin
White Plains, NY
Northeast corridor HNW traction
$12.2M
30% margin
Investment Highlights
Proven Revenue Engine
$57M ARR scaling to $75M+ in 2026. 5 centers with 85%+ recurring membership revenue.
Massive Market Opportunity
$4.2T global wellness market. Longevity is the fastest-growing segment. First-mover advantage in premium diagnostics.
AI-Powered Platform
Zori AI Digital Twin and Precision Health Cloud create a proprietary data moat with 100K+ data points per member.
Path to Profitability
Projecting $6.5M positive EBITDA in 2026. Center-level margins at 39%. Expanding to 6 centers.
Membership Tiers
Core
$10,500/yr
8 AI-Guided Diagnostics, Full Body & Brain MRI, Coronary CT, Whole Genome Sequencing
Apex
Primary Growth Driver$23,500/yr
21 AI-Guided Diagnostics, Cancer Detection Blood Test, Restorative Therapeutics
Apex Elite
$49,500/yr
All Apex + Regen Therapies, Stem Cell Banking, Concierge Medicine, Unlimited Physician Access
Board of Managers
Tony Robbins
Co-Founder & Board Member
Peter Diamandis
Co-Founder & Board Member
Dr. Bill Kapp
Co-Founder, Board Member & CEO
Dr. BK Modi
Board Member
Sam Evans
Board Member
Martin Wiegand
Board Member
Shawn Buchheit
Board Member & President
Confidential — For Qualified Investors Only · Fountain Life Holdings, LLC · March 2026
